12-57091738-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005967.4(NAB2):c.697G>T(p.Gly233Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005967.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAB2 | NM_005967.4 | c.697G>T | p.Gly233Cys | missense_variant | 2/7 | ENST00000300131.8 | NP_005958.1 | |
NAB2 | NM_001330305.2 | c.697G>T | p.Gly233Cys | missense_variant | 2/6 | NP_001317234.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAB2 | ENST00000300131.8 | c.697G>T | p.Gly233Cys | missense_variant | 2/7 | 1 | NM_005967.4 | ENSP00000300131.3 | ||
NAB2 | ENST00000342556.6 | c.697G>T | p.Gly233Cys | missense_variant | 2/6 | 5 | ENSP00000341491.6 | |||
NAB2 | ENST00000554718.1 | n.713G>T | non_coding_transcript_exon_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461772Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727186
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2024 | The c.697G>T (p.G233C) alteration is located in exon 2 (coding exon 2) of the NAB2 gene. This alteration results from a G to T substitution at nucleotide position 697, causing the glycine (G) at amino acid position 233 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.